Alcohol-Based Hand Sanitizers: Does Gelling Agent Really Matter?
COVID-19
alcohol-based hand sanitizers
thickener agents
Journal
Gels (Basel, Switzerland)
ISSN: 2310-2861
Titre abrégé: Gels
Pays: Switzerland
ID NLM: 101696925
Informations de publication
Date de publication:
29 Jan 2022
29 Jan 2022
Historique:
received:
09
12
2021
revised:
22
01
2022
accepted:
26
01
2022
entrez:
24
2
2022
pubmed:
25
2
2022
medline:
25
2
2022
Statut:
epublish
Résumé
Hand hygiene, social distancing, and face covering are considered the first protection against Coronavirus spreading. The high demand during the COVID-19 emergency has driven a frenetic production and marketing of hand sanitizer gels. Nevertheless, the effect of the gelling agent and its amount on the effectiveness of alcohol-based hand sanitizers (ABHSs) needs to be clarified. We presented a systematic study on the effect of the characteristics and concentration of the most employed excipients on the properties and antimicrobial activity of ABHSs. Three different gelling agents, carbopol, hydroxypropylmethylcellulose (HPMC), and hydroxyethylcellulose (HEC), at four different concentrations were used to prepare ABHSs. Viscosity, spreadability, delivery from commercial dispensers, evaporation rate, rubbing time, and hand distribution of the ABHSs were then explored. Biocidal activity of selected ABHSs was evaluated in vitro on ATCC and clinical strains. The studied ABHS can be considered bioactive and comfortable. Nevertheless, the cellulose polymers and ethanol interactions led to a slight but significant reduction in the biocidal activity compared with carbopol-based formulations. Our results underline the importance of the gelling agent properties and support the choice of carbopol as one of the best thickener agents in ABHS formulations.
Identifiants
pubmed: 35200468
pii: gels8020087
doi: 10.3390/gels8020087
pmc: PMC8871833
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Microchem J. 2020 Dec;159:105421
pubmed: 32836390
J Hosp Infect. 2005 May;60(1):32-9
pubmed: 15823654
mSphere. 2021 Mar 3;6(2):
pubmed: 33658274
Int J Pharm. 2020 Jun 30;584:119431
pubmed: 32461194
J Hosp Infect. 2005 Jan;59(1):12-8
pubmed: 15571848
Phys Chem Chem Phys. 2017 Sep 13;19(35):23704-23718
pubmed: 28621781
Am J Infect Control. 2012 Aug;40(6):521-5
pubmed: 22264743
J Infect Public Health. 2020 May;13(5):730-736
pubmed: 32005617
J Hosp Infect. 2002 Jun;51(2):114-20
pubmed: 12090798
Colloids Surf B Biointerfaces. 2017 Jun 1;154:307-314
pubmed: 28371727
Int J Pharm. 2021 Nov 20;609:121139
pubmed: 34592397
Anesth Analg. 1995 Sep;81(3):555-8
pubmed: 7653822
Lancet. 2006 May 27;367(9524):1747-57
pubmed: 16731270
FASEB J. 2021 Dec;35(12):e22026
pubmed: 34818435
J Hosp Infect. 1988 Oct;12(3):163-75
pubmed: 2904456
J Hosp Infect. 2001 Aug;48 Suppl A:S4-8
pubmed: 11759024
Am J Infect Control. 1994 Aug;22(4):224-7
pubmed: 7985822
Am J Infect Control. 2012 May;40(4):328-31
pubmed: 22134012
Eur J Pharm Biopharm. 2002 Nov;54(3):329-35
pubmed: 12445564
J Hosp Infect. 2017 Feb;95(2):175-182
pubmed: 28153555
Pediatr Infect Dis J. 2002 Jun;21(6):489-95
pubmed: 12182370
J Hosp Infect. 1991 Jul;18(3):211-8
pubmed: 1680903
Am J Infect Control. 2020 Sep;48(9):1062-1067
pubmed: 32565272
Int J Pharm. 2021 Jul 15;604:120769
pubmed: 34089795
J Hosp Infect. 1998 Apr;38(4):297-303
pubmed: 9602978
Pharmaceutics. 2021 Apr 17;13(4):
pubmed: 33920509
J Hosp Infect. 2018 Oct;100(2):195-201
pubmed: 30012375
J Hosp Infect. 1999 Jun;42(2):143-50
pubmed: 10389064
Anal Bioanal Chem. 2011 Jun;400(7):1905-11
pubmed: 21442367
Am J Infect Control. 2012 Mar;40(2):160-4
pubmed: 21839542
Am J Infect Control. 2021 Mar;49(3):401-402
pubmed: 32818578